In compliance with Regulation 34(1) of the SEBI (LODR) Regulations, 2015, Rubra Medicaments has informed that it attached Annual Report of the Company for the FY2021-22. Date of Annual General Meeting - September 30, 2022.
The above information is a part of company’s filings submitted to BSE.